Chinese budget retailer eyes HK for US$1b IPO

Also, Tasly Biopharmaceuticals, a biopharma unit of Shanghai-listed Tasly Pharmaceutical Group, plans to raise about US$500 million from a Hong Kong IPO, according to Reuters IFR. Meanwhile, Ernst & ... ( read original story ...)

McKinsey & Company Hong Kong Office | OMA

The design by OMA for the new McKinsey & Company Hong Kong office caters to the consulting firm’s need for a more intimate space that offers a greater sense of collaboration and community. McKinsey ... ( read original story ...)